Global Neoantigen Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Neoantigen Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
This report is a detailed and comprehensive analysis for global Neoantigen Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neoantigen Targeted Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neoantigen Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neoantigen Targeted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna and Agenus, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neoantigen Targeted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Neoantigen Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neoantigen Targeted Therapy, with revenue, gross margin and global market share of Neoantigen Targeted Therapy from 2018 to 2023.
Chapter 3, the Neoantigen Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neoantigen Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neoantigen Targeted Therapy.
Chapter 13, to describe Neoantigen Targeted Therapy research findings and conclusion.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
This report is a detailed and comprehensive analysis for global Neoantigen Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neoantigen Targeted Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neoantigen Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neoantigen Targeted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna and Agenus, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neoantigen Targeted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Off-the-shelf Neoantigen
- Personalized Neoantigen
- Colorectal Cancer
- Renal Cell Carcinoma
- Non-Small Cell Lung cancer
- Bone Cancer
- Gynecological Cancer
- Others
- BioNTech SE
- Gritstone Bio
- Genocea Biosciences
- Moderna
- Agenus
- Immatics
- Advaxis
- Precision Biologics
- Gilead Sciences
- Cellular Biomedicine Group
- Achilles Therapeutics
- Merck and Co
- Beijing Kati Medical Technology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Neoantigen Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neoantigen Targeted Therapy, with revenue, gross margin and global market share of Neoantigen Targeted Therapy from 2018 to 2023.
Chapter 3, the Neoantigen Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neoantigen Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neoantigen Targeted Therapy.
Chapter 13, to describe Neoantigen Targeted Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Neoantigen Targeted Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neoantigen Targeted Therapy by Type
1.3.1 Overview: Global Neoantigen Targeted Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neoantigen Targeted Therapy Consumption Value Market Share by Type in 2022
1.3.3 Off-the-shelf Neoantigen
1.3.4 Personalized Neoantigen
1.4 Global Neoantigen Targeted Therapy Market by Application
1.4.1 Overview: Global Neoantigen Targeted Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Colorectal Cancer
1.4.3 Renal Cell Carcinoma
1.4.4 Non-Small Cell Lung cancer
1.4.5 Bone Cancer
1.4.6 Gynecological Cancer
1.4.7 Others
1.5 Global Neoantigen Targeted Therapy Market Size & Forecast
1.6 Global Neoantigen Targeted Therapy Market Size and Forecast by Region
1.6.1 Global Neoantigen Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neoantigen Targeted Therapy Market Size by Region, (2018-2029)
1.6.3 North America Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 BioNTech SE
2.1.1 BioNTech SE Details
2.1.2 BioNTech SE Major Business
2.1.3 BioNTech SE Neoantigen Targeted Therapy Product and Solutions
2.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BioNTech SE Recent Developments and Future Plans
2.2 Gritstone Bio
2.2.1 Gritstone Bio Details
2.2.2 Gritstone Bio Major Business
2.2.3 Gritstone Bio Neoantigen Targeted Therapy Product and Solutions
2.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gritstone Bio Recent Developments and Future Plans
2.3 Genocea Biosciences
2.3.1 Genocea Biosciences Details
2.3.2 Genocea Biosciences Major Business
2.3.3 Genocea Biosciences Neoantigen Targeted Therapy Product and Solutions
2.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genocea Biosciences Recent Developments and Future Plans
2.4 Moderna
2.4.1 Moderna Details
2.4.2 Moderna Major Business
2.4.3 Moderna Neoantigen Targeted Therapy Product and Solutions
2.4.4 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moderna Recent Developments and Future Plans
2.5 Agenus
2.5.1 Agenus Details
2.5.2 Agenus Major Business
2.5.3 Agenus Neoantigen Targeted Therapy Product and Solutions
2.5.4 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agenus Recent Developments and Future Plans
2.6 Immatics
2.6.1 Immatics Details
2.6.2 Immatics Major Business
2.6.3 Immatics Neoantigen Targeted Therapy Product and Solutions
2.6.4 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Immatics Recent Developments and Future Plans
2.7 Advaxis
2.7.1 Advaxis Details
2.7.2 Advaxis Major Business
2.7.3 Advaxis Neoantigen Targeted Therapy Product and Solutions
2.7.4 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Advaxis Recent Developments and Future Plans
2.8 Precision Biologics
2.8.1 Precision Biologics Details
2.8.2 Precision Biologics Major Business
2.8.3 Precision Biologics Neoantigen Targeted Therapy Product and Solutions
2.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Precision Biologics Recent Developments and Future Plans
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Neoantigen Targeted Therapy Product and Solutions
2.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gilead Sciences Recent Developments and Future Plans
2.10 Cellular Biomedicine Group
2.10.1 Cellular Biomedicine Group Details
2.10.2 Cellular Biomedicine Group Major Business
2.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Solutions
2.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cellular Biomedicine Group Recent Developments and Future Plans
2.11 Achilles Therapeutics
2.11.1 Achilles Therapeutics Details
2.11.2 Achilles Therapeutics Major Business
2.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Product and Solutions
2.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Achilles Therapeutics Recent Developments and Future Plans
2.12 Merck and Co
2.12.1 Merck and Co Details
2.12.2 Merck and Co Major Business
2.12.3 Merck and Co Neoantigen Targeted Therapy Product and Solutions
2.12.4 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Merck and Co Recent Developments and Future Plans
2.13 Beijing Kati Medical Technology
2.13.1 Beijing Kati Medical Technology Details
2.13.2 Beijing Kati Medical Technology Major Business
2.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Solutions
2.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing Kati Medical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neoantigen Targeted Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neoantigen Targeted Therapy by Company Revenue
3.2.2 Top 3 Neoantigen Targeted Therapy Players Market Share in 2022
3.2.3 Top 6 Neoantigen Targeted Therapy Players Market Share in 2022
3.3 Neoantigen Targeted Therapy Market: Overall Company Footprint Analysis
3.3.1 Neoantigen Targeted Therapy Market: Region Footprint
3.3.2 Neoantigen Targeted Therapy Market: Company Product Type Footprint
3.3.3 Neoantigen Targeted Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neoantigen Targeted Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neoantigen Targeted Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Neoantigen Targeted Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
6.2 North America Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
6.3 North America Neoantigen Targeted Therapy Market Size by Country
6.3.1 North America Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
7.2 Europe Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
7.3 Europe Neoantigen Targeted Therapy Market Size by Country
7.3.1 Europe Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.3 France Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region
8.3.1 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2018-2029)
8.3.2 China Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.5 India Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
9.2 South America Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
9.3 South America Neoantigen Targeted Therapy Market Size by Country
9.3.1 South America Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country
10.3.1 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Neoantigen Targeted Therapy Market Drivers
11.2 Neoantigen Targeted Therapy Market Restraints
11.3 Neoantigen Targeted Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Neoantigen Targeted Therapy Industry Chain
12.2 Neoantigen Targeted Therapy Upstream Analysis
12.3 Neoantigen Targeted Therapy Midstream Analysis
12.4 Neoantigen Targeted Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Neoantigen Targeted Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neoantigen Targeted Therapy by Type
1.3.1 Overview: Global Neoantigen Targeted Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neoantigen Targeted Therapy Consumption Value Market Share by Type in 2022
1.3.3 Off-the-shelf Neoantigen
1.3.4 Personalized Neoantigen
1.4 Global Neoantigen Targeted Therapy Market by Application
1.4.1 Overview: Global Neoantigen Targeted Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Colorectal Cancer
1.4.3 Renal Cell Carcinoma
1.4.4 Non-Small Cell Lung cancer
1.4.5 Bone Cancer
1.4.6 Gynecological Cancer
1.4.7 Others
1.5 Global Neoantigen Targeted Therapy Market Size & Forecast
1.6 Global Neoantigen Targeted Therapy Market Size and Forecast by Region
1.6.1 Global Neoantigen Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neoantigen Targeted Therapy Market Size by Region, (2018-2029)
1.6.3 North America Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 BioNTech SE
2.1.1 BioNTech SE Details
2.1.2 BioNTech SE Major Business
2.1.3 BioNTech SE Neoantigen Targeted Therapy Product and Solutions
2.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BioNTech SE Recent Developments and Future Plans
2.2 Gritstone Bio
2.2.1 Gritstone Bio Details
2.2.2 Gritstone Bio Major Business
2.2.3 Gritstone Bio Neoantigen Targeted Therapy Product and Solutions
2.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gritstone Bio Recent Developments and Future Plans
2.3 Genocea Biosciences
2.3.1 Genocea Biosciences Details
2.3.2 Genocea Biosciences Major Business
2.3.3 Genocea Biosciences Neoantigen Targeted Therapy Product and Solutions
2.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genocea Biosciences Recent Developments and Future Plans
2.4 Moderna
2.4.1 Moderna Details
2.4.2 Moderna Major Business
2.4.3 Moderna Neoantigen Targeted Therapy Product and Solutions
2.4.4 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moderna Recent Developments and Future Plans
2.5 Agenus
2.5.1 Agenus Details
2.5.2 Agenus Major Business
2.5.3 Agenus Neoantigen Targeted Therapy Product and Solutions
2.5.4 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agenus Recent Developments and Future Plans
2.6 Immatics
2.6.1 Immatics Details
2.6.2 Immatics Major Business
2.6.3 Immatics Neoantigen Targeted Therapy Product and Solutions
2.6.4 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Immatics Recent Developments and Future Plans
2.7 Advaxis
2.7.1 Advaxis Details
2.7.2 Advaxis Major Business
2.7.3 Advaxis Neoantigen Targeted Therapy Product and Solutions
2.7.4 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Advaxis Recent Developments and Future Plans
2.8 Precision Biologics
2.8.1 Precision Biologics Details
2.8.2 Precision Biologics Major Business
2.8.3 Precision Biologics Neoantigen Targeted Therapy Product and Solutions
2.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Precision Biologics Recent Developments and Future Plans
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Neoantigen Targeted Therapy Product and Solutions
2.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gilead Sciences Recent Developments and Future Plans
2.10 Cellular Biomedicine Group
2.10.1 Cellular Biomedicine Group Details
2.10.2 Cellular Biomedicine Group Major Business
2.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Solutions
2.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cellular Biomedicine Group Recent Developments and Future Plans
2.11 Achilles Therapeutics
2.11.1 Achilles Therapeutics Details
2.11.2 Achilles Therapeutics Major Business
2.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Product and Solutions
2.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Achilles Therapeutics Recent Developments and Future Plans
2.12 Merck and Co
2.12.1 Merck and Co Details
2.12.2 Merck and Co Major Business
2.12.3 Merck and Co Neoantigen Targeted Therapy Product and Solutions
2.12.4 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Merck and Co Recent Developments and Future Plans
2.13 Beijing Kati Medical Technology
2.13.1 Beijing Kati Medical Technology Details
2.13.2 Beijing Kati Medical Technology Major Business
2.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Solutions
2.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing Kati Medical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neoantigen Targeted Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neoantigen Targeted Therapy by Company Revenue
3.2.2 Top 3 Neoantigen Targeted Therapy Players Market Share in 2022
3.2.3 Top 6 Neoantigen Targeted Therapy Players Market Share in 2022
3.3 Neoantigen Targeted Therapy Market: Overall Company Footprint Analysis
3.3.1 Neoantigen Targeted Therapy Market: Region Footprint
3.3.2 Neoantigen Targeted Therapy Market: Company Product Type Footprint
3.3.3 Neoantigen Targeted Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neoantigen Targeted Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neoantigen Targeted Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Neoantigen Targeted Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
6.2 North America Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
6.3 North America Neoantigen Targeted Therapy Market Size by Country
6.3.1 North America Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
7.2 Europe Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
7.3 Europe Neoantigen Targeted Therapy Market Size by Country
7.3.1 Europe Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.3 France Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region
8.3.1 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2018-2029)
8.3.2 China Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.5 India Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
9.2 South America Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
9.3 South America Neoantigen Targeted Therapy Market Size by Country
9.3.1 South America Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country
10.3.1 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Neoantigen Targeted Therapy Market Drivers
11.2 Neoantigen Targeted Therapy Market Restraints
11.3 Neoantigen Targeted Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Neoantigen Targeted Therapy Industry Chain
12.2 Neoantigen Targeted Therapy Upstream Analysis
12.3 Neoantigen Targeted Therapy Midstream Analysis
12.4 Neoantigen Targeted Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Neoantigen Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neoantigen Targeted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Neoantigen Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Neoantigen Targeted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. BioNTech SE Company Information, Head Office, and Major Competitors
Table 6. BioNTech SE Major Business
Table 7. BioNTech SE Neoantigen Targeted Therapy Product and Solutions
Table 8. BioNTech SE Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. BioNTech SE Recent Developments and Future Plans
Table 10. Gritstone Bio Company Information, Head Office, and Major Competitors
Table 11. Gritstone Bio Major Business
Table 12. Gritstone Bio Neoantigen Targeted Therapy Product and Solutions
Table 13. Gritstone Bio Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Gritstone Bio Recent Developments and Future Plans
Table 15. Genocea Biosciences Company Information, Head Office, and Major Competitors
Table 16. Genocea Biosciences Major Business
Table 17. Genocea Biosciences Neoantigen Targeted Therapy Product and Solutions
Table 18. Genocea Biosciences Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Genocea Biosciences Recent Developments and Future Plans
Table 20. Moderna Company Information, Head Office, and Major Competitors
Table 21. Moderna Major Business
Table 22. Moderna Neoantigen Targeted Therapy Product and Solutions
Table 23. Moderna Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Moderna Recent Developments and Future Plans
Table 25. Agenus Company Information, Head Office, and Major Competitors
Table 26. Agenus Major Business
Table 27. Agenus Neoantigen Targeted Therapy Product and Solutions
Table 28. Agenus Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agenus Recent Developments and Future Plans
Table 30. Immatics Company Information, Head Office, and Major Competitors
Table 31. Immatics Major Business
Table 32. Immatics Neoantigen Targeted Therapy Product and Solutions
Table 33. Immatics Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Immatics Recent Developments and Future Plans
Table 35. Advaxis Company Information, Head Office, and Major Competitors
Table 36. Advaxis Major Business
Table 37. Advaxis Neoantigen Targeted Therapy Product and Solutions
Table 38. Advaxis Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Advaxis Recent Developments and Future Plans
Table 40. Precision Biologics Company Information, Head Office, and Major Competitors
Table 41. Precision Biologics Major Business
Table 42. Precision Biologics Neoantigen Targeted Therapy Product and Solutions
Table 43. Precision Biologics Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Precision Biologics Recent Developments and Future Plans
Table 45. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 46. Gilead Sciences Major Business
Table 47. Gilead Sciences Neoantigen Targeted Therapy Product and Solutions
Table 48. Gilead Sciences Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Gilead Sciences Recent Developments and Future Plans
Table 50. Cellular Biomedicine Group Company Information, Head Office, and Major Competitors
Table 51. Cellular Biomedicine Group Major Business
Table 52. Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Solutions
Table 53. Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cellular Biomedicine Group Recent Developments and Future Plans
Table 55. Achilles Therapeutics Company Information, Head Office, and Major Competitors
Table 56. Achilles Therapeutics Major Business
Table 57. Achilles Therapeutics Neoantigen Targeted Therapy Product and Solutions
Table 58. Achilles Therapeutics Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Achilles Therapeutics Recent Developments and Future Plans
Table 60. Merck and Co Company Information, Head Office, and Major Competitors
Table 61. Merck and Co Major Business
Table 62. Merck and Co Neoantigen Targeted Therapy Product and Solutions
Table 63. Merck and Co Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Merck and Co Recent Developments and Future Plans
Table 65. Beijing Kati Medical Technology Company Information, Head Office, and Major Competitors
Table 66. Beijing Kati Medical Technology Major Business
Table 67. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Solutions
Table 68. Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Beijing Kati Medical Technology Recent Developments and Future Plans
Table 70. Global Neoantigen Targeted Therapy Revenue (USD Million) by Players (2018-2023)
Table 71. Global Neoantigen Targeted Therapy Revenue Share by Players (2018-2023)
Table 72. Breakdown of Neoantigen Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Neoantigen Targeted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Neoantigen Targeted Therapy Players
Table 75. Neoantigen Targeted Therapy Market: Company Product Type Footprint
Table 76. Neoantigen Targeted Therapy Market: Company Product Application Footprint
Table 77. Neoantigen Targeted Therapy New Market Entrants and Barriers to Market Entry
Table 78. Neoantigen Targeted Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Neoantigen Targeted Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Neoantigen Targeted Therapy Consumption Value Share by Type (2018-2023)
Table 81. Global Neoantigen Targeted Therapy Consumption Value Forecast by Type (2024-2029)
Table 82. Global Neoantigen Targeted Therapy Consumption Value by Application (2018-2023)
Table 83. Global Neoantigen Targeted Therapy Consumption Value Forecast by Application (2024-2029)
Table 84. North America Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Neoantigen Targeted Therapy Raw Material
Table 115. Key Suppliers of Neoantigen Targeted Therapy Raw Materials
Table 1. Global Neoantigen Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neoantigen Targeted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Neoantigen Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Neoantigen Targeted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. BioNTech SE Company Information, Head Office, and Major Competitors
Table 6. BioNTech SE Major Business
Table 7. BioNTech SE Neoantigen Targeted Therapy Product and Solutions
Table 8. BioNTech SE Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. BioNTech SE Recent Developments and Future Plans
Table 10. Gritstone Bio Company Information, Head Office, and Major Competitors
Table 11. Gritstone Bio Major Business
Table 12. Gritstone Bio Neoantigen Targeted Therapy Product and Solutions
Table 13. Gritstone Bio Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Gritstone Bio Recent Developments and Future Plans
Table 15. Genocea Biosciences Company Information, Head Office, and Major Competitors
Table 16. Genocea Biosciences Major Business
Table 17. Genocea Biosciences Neoantigen Targeted Therapy Product and Solutions
Table 18. Genocea Biosciences Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Genocea Biosciences Recent Developments and Future Plans
Table 20. Moderna Company Information, Head Office, and Major Competitors
Table 21. Moderna Major Business
Table 22. Moderna Neoantigen Targeted Therapy Product and Solutions
Table 23. Moderna Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Moderna Recent Developments and Future Plans
Table 25. Agenus Company Information, Head Office, and Major Competitors
Table 26. Agenus Major Business
Table 27. Agenus Neoantigen Targeted Therapy Product and Solutions
Table 28. Agenus Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agenus Recent Developments and Future Plans
Table 30. Immatics Company Information, Head Office, and Major Competitors
Table 31. Immatics Major Business
Table 32. Immatics Neoantigen Targeted Therapy Product and Solutions
Table 33. Immatics Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Immatics Recent Developments and Future Plans
Table 35. Advaxis Company Information, Head Office, and Major Competitors
Table 36. Advaxis Major Business
Table 37. Advaxis Neoantigen Targeted Therapy Product and Solutions
Table 38. Advaxis Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Advaxis Recent Developments and Future Plans
Table 40. Precision Biologics Company Information, Head Office, and Major Competitors
Table 41. Precision Biologics Major Business
Table 42. Precision Biologics Neoantigen Targeted Therapy Product and Solutions
Table 43. Precision Biologics Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Precision Biologics Recent Developments and Future Plans
Table 45. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 46. Gilead Sciences Major Business
Table 47. Gilead Sciences Neoantigen Targeted Therapy Product and Solutions
Table 48. Gilead Sciences Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Gilead Sciences Recent Developments and Future Plans
Table 50. Cellular Biomedicine Group Company Information, Head Office, and Major Competitors
Table 51. Cellular Biomedicine Group Major Business
Table 52. Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Solutions
Table 53. Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cellular Biomedicine Group Recent Developments and Future Plans
Table 55. Achilles Therapeutics Company Information, Head Office, and Major Competitors
Table 56. Achilles Therapeutics Major Business
Table 57. Achilles Therapeutics Neoantigen Targeted Therapy Product and Solutions
Table 58. Achilles Therapeutics Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Achilles Therapeutics Recent Developments and Future Plans
Table 60. Merck and Co Company Information, Head Office, and Major Competitors
Table 61. Merck and Co Major Business
Table 62. Merck and Co Neoantigen Targeted Therapy Product and Solutions
Table 63. Merck and Co Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Merck and Co Recent Developments and Future Plans
Table 65. Beijing Kati Medical Technology Company Information, Head Office, and Major Competitors
Table 66. Beijing Kati Medical Technology Major Business
Table 67. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Solutions
Table 68. Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Beijing Kati Medical Technology Recent Developments and Future Plans
Table 70. Global Neoantigen Targeted Therapy Revenue (USD Million) by Players (2018-2023)
Table 71. Global Neoantigen Targeted Therapy Revenue Share by Players (2018-2023)
Table 72. Breakdown of Neoantigen Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Neoantigen Targeted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Neoantigen Targeted Therapy Players
Table 75. Neoantigen Targeted Therapy Market: Company Product Type Footprint
Table 76. Neoantigen Targeted Therapy Market: Company Product Application Footprint
Table 77. Neoantigen Targeted Therapy New Market Entrants and Barriers to Market Entry
Table 78. Neoantigen Targeted Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Neoantigen Targeted Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Neoantigen Targeted Therapy Consumption Value Share by Type (2018-2023)
Table 81. Global Neoantigen Targeted Therapy Consumption Value Forecast by Type (2024-2029)
Table 82. Global Neoantigen Targeted Therapy Consumption Value by Application (2018-2023)
Table 83. Global Neoantigen Targeted Therapy Consumption Value Forecast by Application (2024-2029)
Table 84. North America Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Neoantigen Targeted Therapy Raw Material
Table 115. Key Suppliers of Neoantigen Targeted Therapy Raw Materials
LIST OF FIGURES
Figure 1. Neoantigen Targeted Therapy Picture
Figure 2. Global Neoantigen Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neoantigen Targeted Therapy Consumption Value Market Share by Type in 2022
Figure 4. Off-the-shelf Neoantigen
Figure 5. Personalized Neoantigen
Figure 6. Global Neoantigen Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Neoantigen Targeted Therapy Consumption Value Market Share by Application in 2022
Figure 8. Colorectal Cancer Picture
Figure 9. Renal Cell Carcinoma Picture
Figure 10. Non-Small Cell Lung cancer Picture
Figure 11. Bone Cancer Picture
Figure 12. Gynecological Cancer Picture
Figure 13. Others Picture
Figure 14. Global Neoantigen Targeted Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Neoantigen Targeted Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Neoantigen Targeted Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Neoantigen Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Neoantigen Targeted Therapy Consumption Value Market Share by Region in 2022
Figure 19. North America Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Neoantigen Targeted Therapy Revenue Share by Players in 2022
Figure 25. Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Neoantigen Targeted Therapy Market Share in 2022
Figure 27. Global Top 6 Players Neoantigen Targeted Therapy Market Share in 2022
Figure 28. Global Neoantigen Targeted Therapy Consumption Value Share by Type (2018-2023)
Figure 29. Global Neoantigen Targeted Therapy Market Share Forecast by Type (2024-2029)
Figure 30. Global Neoantigen Targeted Therapy Consumption Value Share by Application (2018-2023)
Figure 31. Global Neoantigen Targeted Therapy Market Share Forecast by Application (2024-2029)
Figure 32. North America Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. France Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Neoantigen Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 49. China Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. India Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 66. Neoantigen Targeted Therapy Market Drivers
Figure 67. Neoantigen Targeted Therapy Market Restraints
Figure 68. Neoantigen Targeted Therapy Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neoantigen Targeted Therapy in 2022
Figure 71. Manufacturing Process Analysis of Neoantigen Targeted Therapy
Figure 72. Neoantigen Targeted Therapy Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Neoantigen Targeted Therapy Picture
Figure 2. Global Neoantigen Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neoantigen Targeted Therapy Consumption Value Market Share by Type in 2022
Figure 4. Off-the-shelf Neoantigen
Figure 5. Personalized Neoantigen
Figure 6. Global Neoantigen Targeted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Neoantigen Targeted Therapy Consumption Value Market Share by Application in 2022
Figure 8. Colorectal Cancer Picture
Figure 9. Renal Cell Carcinoma Picture
Figure 10. Non-Small Cell Lung cancer Picture
Figure 11. Bone Cancer Picture
Figure 12. Gynecological Cancer Picture
Figure 13. Others Picture
Figure 14. Global Neoantigen Targeted Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Neoantigen Targeted Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Neoantigen Targeted Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Neoantigen Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Neoantigen Targeted Therapy Consumption Value Market Share by Region in 2022
Figure 19. North America Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Neoantigen Targeted Therapy Revenue Share by Players in 2022
Figure 25. Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Neoantigen Targeted Therapy Market Share in 2022
Figure 27. Global Top 6 Players Neoantigen Targeted Therapy Market Share in 2022
Figure 28. Global Neoantigen Targeted Therapy Consumption Value Share by Type (2018-2023)
Figure 29. Global Neoantigen Targeted Therapy Market Share Forecast by Type (2024-2029)
Figure 30. Global Neoantigen Targeted Therapy Consumption Value Share by Application (2018-2023)
Figure 31. Global Neoantigen Targeted Therapy Market Share Forecast by Application (2024-2029)
Figure 32. North America Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. France Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Neoantigen Targeted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 49. China Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. India Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Neoantigen Targeted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Neoantigen Targeted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Neoantigen Targeted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 66. Neoantigen Targeted Therapy Market Drivers
Figure 67. Neoantigen Targeted Therapy Market Restraints
Figure 68. Neoantigen Targeted Therapy Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neoantigen Targeted Therapy in 2022
Figure 71. Manufacturing Process Analysis of Neoantigen Targeted Therapy
Figure 72. Neoantigen Targeted Therapy Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
